|
|
DSpace at RU >
Browsing by Author Wissen, S. van
Showing results 1 to 6 of 6
| Full Text | Issue Date | Title | Author(s) | | 2005 | Long-term safety and efficacy of high-dose atorvastatin treatment in patients with familial hypercholesterolemia. | Wissen, S. van; Smilde, T.J.; Trip, M.D.; Stalenhoef, A.F.H.; Kastelein, J.J.P. |
| 2004 | Effects of atorvastatin and simvastatin on low-density lipoprotein subfraction profile, low-density lipoprotein oxidizability, and antibodies to oxidized low-density lipoprotein in relation to carotid intima media thickness in familial hypercholesterolemia. | Tits, L.J.H. van; Smilde, T.J.; Wissen, S. van; Graaf, J. de; Kastelein, J.J.P., et al |
| 2004 | Toll-like receptor-4 Asp299Gly polymorphism does not influence progression of atherosclerosis in patients with familial hypercholesterolaemia | Netea, M.G.; Hijmans, A.; Wissen, S. van; Smilde, T.J.; Trip, M.D., et al |
| 2004 | The relationship between cholesteryl ester transfer protein levels and risk factor profile in patients with familial hypercholesterolemia. | Grooth, G.J. de; Smilde, T.J.; Wissen, S. van; Klerkx, A.H.; Zwinderman, A.H., et al |
| 2004 | Toll-like receptor-r Asp299Gly polymorphism does not influence progression of atherosclerosis in patients with familial hypercholesterolaemia. | Netea, M.G.; Hijmans, A.G.M.; Wissen, S. van; Smilde, T.J.; Trip, M.D., et al |
| 2004 | Toll-like receptor-4 Asp299Gly polymorphism does not influence progression of atherosclerosis in patients with familial hypercholesterolemia (Erratum: vol 34, pg 94, 2004) | Netea, M.G.; Hijmans, A.; Wissen, S. van; Smilde, T.J.; Trip, M.D., et al |
Showing results 1 to 6 of 6
|